Transaction DateRecipientSharesTypePriceValue
15th September 2020Advisors Llc Orbimed292,607Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed902,885Grant/award etc.$0.00
15th September 2020Carl L Gordon292,607Grant/award etc.$0.00
15th September 2020Advisors Llc Orbimed4,822,960Grant/award etc.$0.00
15th September 2020Carl L Gordon902,885Grant/award etc.$0.00
15th September 2020Carl L Gordon4,822,960Grant/award etc.$0.00
18th August 2020Advisors Llc Orbimed43,543Open or private sale$108.54$4,726,157.22
17th August 2020Advisors Llc Orbimed94,900Open or private sale$107.49$10,200,801.00
14th August 2020Advisors Llc Orbimed20,257Open or private sale$109.03$2,208,620.71
13th August 2020Advisors Llc Orbimed29,251Open or private sale$109.93$3,215,562.43
Turning Point Therapeutics
Turning Point Therapeutics logo

Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.

Ticker: TPTX
Sector: Health Technology
Industry: Pharmaceuticals: Major
SEC Central Index Key (CIK): 1595893
Employees: 95
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals